The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study

Abstract

BACKGROUND: The COVID-19 pandemic has placed unprecedented strain on health-care systems. Frailty is being used in clinical decision making for patients with COVID-19, yet the prevalence and effect of frailty in people with COVID-19 is not known. In the COVID-19 in Older PEople (COPE) study we aimed to establish the prevalence of frailty in patients with COVID-19 who were admitted to hospital and investigate its association with mortality and duration of hospital stay. METHODS: This was an observational cohort study conducted at ten hospitals in the UK and one in Italy. All adults (≥18 years) admitted to participating hospitals with COVID-19 were included. Patients with incomplete hospital records were excluded. The study analysed routinely generated hospital data for patients with COVID-19. Frailty was assessed by specialist COVID-19 teams using the clinical frailty scale (CFS) and patients were grouped according to their score (1-2=fit; 3-4=vulnerable, but not frail; 5-6=initial signs of frailty but with some degree of independence; and 7-9=severe or very severe frailty). The primary outcome was in-hospital mortality (time from hospital admission to mortality and day-7 mortality). FINDINGS: Between Feb 27, and April 28, 2020, we enrolled 1564 patients with COVID-19. The median age was 74 years (IQR 61-83); 903 (57·7%) were men and 661 (42·3%) were women; 425 (27·2%) had died at data cutoff (April 28, 2020). 772 (49·4%) were classed as frail (CFS 5-8) and 27 (1·7%) were classed as terminally ill (CFS 9). Compared with CFS 1-2, the adjusted hazard ratios for time from hospital admission to death were 1·55 (95% CI 1·00-2·41) for CFS 3-4, 1·83 (1·15-2·91) for CFS 5-6, and 2·39 (1·50-3·81) for CFS 7-9, and adjusted odds ratios for day-7 mortality were 1·22 (95% CI 0·63-2·38) for CFS 3-4, 1·62 (0·81-3·26) for CFS 5-6, and 3·12 (1·56-6·24) for CFS 7-9. INTERPRETATION: In a large population of patients admitted to hospital with COVID-19, disease outcomes were better predicted by frailty than either age or comorbidity. Our results support the use of CFS to inform decision making about medical care in adult patients admitted to hospital with COVID-19. FUNDING: None.

Cited by papers we hold 14

• Static Socio-Ecological COVID-19 Vulnerability Index and Vaccine Hesitancy Index for England · 2022
  Not checked
• Use of clinical frailty scale in acute care settings as a predictor of in-hospital and short-term mortality in older adults with severe acute respiratory illness: A prospective pilot cohort study from India · 2021
  Not checked
• Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study · 2021
  No notice
• Screening for Sarcopenia (Physical Frailty) in the COVID-19 Era · 2021
  Not checked
• The role of SARC-F scale in predicting progression risk of COVID-19 in elderly patients: a prospective cohort study in Wuhan · 2021
  Not checked
• Identifying Frail Populations for Disease Risk Prediction and Intervention Planning in the Covid-19 Era: A Focus on Social Isolation and Vulnerability · 2021
  Not checked
• Web-based software applications for frailty assessment in older adults: a scoping review of current status with insights into future development · 2021
  Not checked
• The role of C-reactive protein as a prognostic marker in COVID-19 · 2021
  No notice
• Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence · 2021
  No notice
• The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19 · 2020
  Not checked
• Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank · 2020
  Not checked
• Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study · 2020
  No notice
• Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study · 2020
  No notice
• Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.